Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Hongbing
Hongbing Lu, Edmond, OK US
| Patent application number | Description | Published |
|---|---|---|
| 20090036646 | DRYING PROCESS FOR POLYMER CROSSLINKED BI-CONTINUOUS MACRO-MESOPOROUS AEROGELS - A method of drying an aerogel is disclosed. The method includes washing the aerogel in acetone, washing the aerogel in pentane, and heating the aerogel in the presence of pentane. The aerogel is removed from the pentane and the heating continues. | 02-05-2009 |
Hongbing Shen US
| Patent application number | Description | Published |
|---|---|---|
| 20110051825 | A MULTI-CARRIER DIGITAL MOBILE MULTIMEDIA BROADCAST SYSTEM AND THE DIGITAL INFORMATION TRANSMISSION METHOD THEREOF - The present invention discloses a multi-carrier digital multimedia broadcast system and the digital information transmission method thereof. After RS encoding and byte interleaving, LDPC encoding, bit interleaving and constellation mapping to an upper layer of data streams in turn, the obtained data symbol is multiplexed with scattered pilots and continual pilots which include the system information to form an OFDM frequency domain symbol and scrambled; an OFDM time domain symbol is generated by IFFT transforming, and after inserted with the frame head to build a time slot, it is connected to form a signal frame of the physical layer; the signal frame of the physical layer is transmitted after being low-pass filtered and orthogonal upconverted. The system and method thereof provide wireless broadcast with high quality such as audio, video and multimedia data and the like for mobile, fixed and portable receivers, and can use the satellite transmission and terrestrial transmission method for transmitting. The method utilizes the LDPC OFDM scheme, and the system applies the microwave and large scale integrated circuit technologies while fulfills the needs for low cast and high performance. | 03-03-2011 |
Hongbing Zhang, Albany, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080254033 | Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases - The present invention provides LRP4, LRP8 and LRP2 (megalin) polypeptides; polynucleotides encoding such; modulators of LRP4, LRP8 and LRP2 activity; and pharmaceutical compositions for the treatment of diseases. Compositions of the invention contain a pharmaceutically acceptable carrier or excipient and at least one modulator that is capable of binding to or interfering with the activity of LRP4, LRP8, LRP2 and active fragments thereof. The invention provides modulators, such as antibodies, RNAi molecules, anti-sense molecules and ribozymes. Additionally, the invention includes methods for the treatment of diseases, such as proliferative diseases and degenerative diseases, and methods of administration of the compositions of the invention. | 10-16-2008 |
| 20090018061 | Compositions and Methods for Treating Cardiac Conditions - Pharmaceutical polypeptide compositions promote the survival of cardiac cells, recruit cardiac cells to the cardiac area, stimulate the differentiation of cardiac cells, stimulate the proliferation of cardiac cells, and promote the activity of cardiac cells, thereby treating cardiac conditions. Methods of providing these compositions to the cardiac area include catheterization and direct injection. In preferred embodiments, the compositions comprise one of more of the following growth factors: EGF, hFGF, cardiotrophin-1, thrombin, PDGF-BB, amphiregulin, epiregulin, HB-EGF, TGFalpha, betacellulin, heregulin alpha, NRG-1-beta1-HRG-beta1, FGF 9. | 01-15-2009 |
| 20100158911 | Compositions and Methods of Treating Disease with FGFR Fusion Proteins - The invention provides FGFR fusion proteins, methods of making them, and methods of using them to treat proliferative disorders, including cancers and disorders of angiogenesis. The FGFR fusion molecules can be made in CHO cells and may comprise deletion mutations in the extracellular domains of the FGFRs which improve their stability. These fusion proteins inhibit the growth and viability of cancer cells in vitro and in vivo. The combination of the relatively high affinity of these receptors for their ligand FGFs and the demonstrated ability of these decoy receptors to inhibit tumor growth is an indication of the clinical value of the compositions and methods provided herein. | 06-24-2010 |
Hongbing Zhang, Shanghai CN
| Patent application number | Description | Published |
|---|---|---|
| 20090300230 | Systems and Methods for Improved Hardware Device Connectivity - Systems and methods are described herein to provide for improved hardware device connectivity. Other embodiments include apparatus and system for receiving messages from an operating system and sending messages to one or more hardware devices. Further embodiments include methods for receiving messages from an operating system regarding operations on a hardware device and responding to those messages. Other embodiments include methods for receiving interrupt messages and mapping those interrupt messages to hardware devices. Other embodiments are described and claimed. | 12-03-2009 |